562 related articles for article (PubMed ID: 29244809)
1. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE
PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
[TBL] [Abstract][Full Text] [Related]
3. The HIV care continuum and HIV-1 drug resistance among female sex workers: a key population in Guinea-Bissau.
Lindman J; Djalo MA; Biai A; Månsson F; Esbjörnsson J; Jansson M; Medstrand P; Norrgren H;
AIDS Res Ther; 2020 Jun; 17(1):33. PubMed ID: 32532294
[TBL] [Abstract][Full Text] [Related]
4. High Level of HIV Drug Resistance and Virologic Nonsuppression Among Female Sex Workers in Ethiopia: A Nationwide Cross-Sectional Study.
Arimide DA; Amogne MD; Kebede Y; Balcha TT; Adugna F; Ramos A; DeVos J; Zeh C; Agardh A; Chih-Wei Chang J; Björkman P; Medstrand P
J Acquir Immune Defic Syndr; 2022 Apr; 89(5):566-574. PubMed ID: 34966147
[TBL] [Abstract][Full Text] [Related]
5. Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
Musengimana G; Tuyishime E; Kiromera A; Malamba SS; Mulindabigwi A; Habimana MR; Baribwira C; Ribakare M; Habimana SD; DeVos J; Mwesigwa RCN; Kayirangwa E; Semuhore JM; Rwibasira GN; Suthar AB; Remera E
Antivir Ther; 2022 Jun; 27(3):13596535221102690. PubMed ID: 35593031
[TBL] [Abstract][Full Text] [Related]
6. Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986-2020.
Nduva GM; Otieno F; Kimani J; Sein Y; Arimide DA; Mckinnon LR; Cholette F; Lawrence MK; Majiwa M; Masika M; Mutua G; Anzala O; Graham SM; Gelmon L; Price MA; Smith AD; Bailey RC; Medstrand P; Sanders EJ; Esbjörnsson J; Hassan AS
J Antimicrob Chemother; 2024 Feb; 79(2):287-296. PubMed ID: 38091580
[TBL] [Abstract][Full Text] [Related]
7. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.
Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM
AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647
[TBL] [Abstract][Full Text] [Related]
8. High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam.
Bwire GM; Aiko BG; Mosha IH; Kilapilo MS; Mangara A; Kazonda P; Swai JP; Swalehe O; Jordan MR; Vercauteren J; Sando D; Temba D; Shao A; Mauka W; Decouttere C; Vandaele N; Sangeda RZ; Killewo J; Vandamme AM
Sci Rep; 2023 Nov; 13(1):20493. PubMed ID: 37993493
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 drug resistance and associated factors among adults failing first-line highly active antiretroviral therapy in Ho Chi Minh City, Vietnam.
Pham QD; Huynh TK; Luong TT; Tran T; Vu TX; Truong LX
HIV Clin Trials; 2013; 14(1):34-44. PubMed ID: 23372113
[TBL] [Abstract][Full Text] [Related]
10. Age and CD4+ T cell counts are inversely associated with HIV drug resistance mutations in treatment naive female sex workers.
Mulinge MM; Oluoch JO; Abisi HK; Otieno LE; Anzala O; Wamalwa DC; Nduati RW; Kimani J; Herbeck J; McKinnon L
Medicine (Baltimore); 2023 Jun; 102(24):e34060. PubMed ID: 37327289
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009).
Parikh UM; Kiepiela P; Ganesh S; Gomez K; Horn S; Eskay K; Kelly C; Mensch B; Gorbach P; Soto-Torres L; Ramjee G; Mellors JW;
PLoS One; 2013; 8(4):e59787. PubMed ID: 23585827
[TBL] [Abstract][Full Text] [Related]
12. Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China.
Liu P; You Y; Liao L; Feng Y; Shao Y; Xing H; Lan G; Li J; Ruan Y; Li D
BMC Infect Dis; 2022 May; 22(1):426. PubMed ID: 35509014
[TBL] [Abstract][Full Text] [Related]
13. Cross-sectional study of female sex workers in Soweto, South Africa: Factors associated with HIV infection.
Coetzee J; Jewkes R; Gray GE
PLoS One; 2017; 12(10):e0184775. PubMed ID: 28981511
[TBL] [Abstract][Full Text] [Related]
14. Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa.
Parboosing R; Naidoo A; Gordon M; Taylor M; Vella V
J Med Virol; 2011 Sep; 83(9):1508-13. PubMed ID: 21739439
[TBL] [Abstract][Full Text] [Related]
15. Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda.
Rusine J; Asiimwe-Kateera B; van de Wijgert J; Boer KR; Mukantwali E; Karita E; Gasengayire A; Jurriaans S; de Jong M; Ondoa P
PLoS One; 2013; 8(8):e64345. PubMed ID: 23950859
[TBL] [Abstract][Full Text] [Related]
16. High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda.
Segujja F; Omooja J; Lunkuse S; Nanyonjo M; Nabirye SE; Nassolo F; Bugembe DL; Bbosa N; Kateete DP; Ssenyonga W; Mayanja Y; Nsubuga RN; Seeley J; Kaleebu P; Ssemwanga D
AIDS Res Hum Retroviruses; 2020 Sep; 36(9):782-791. PubMed ID: 32475121
[TBL] [Abstract][Full Text] [Related]
17. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.
Steegen K; Carmona S; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; MacLeod W; Sanne I; Stevens WS
PLoS One; 2016; 11(12):e0166305. PubMed ID: 27907009
[TBL] [Abstract][Full Text] [Related]
18. HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey.
Moyo S; Hunt G; Zuma K; Zungu M; Marinda E; Mabaso M; Kana V; Kalimashe M; Ledwaba J; Naidoo I; Takatshana S; Matjokotja T; Dietrich C; Raizes E; Diallo K; Kindra G; Mugore L; Rehle T
PLoS One; 2020; 15(11):e0241071. PubMed ID: 33147285
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
[TBL] [Abstract][Full Text] [Related]
20. [Study on the relationship between HIV drug resistance and CD4(+)T cell counts among antiretroviral therapy patients with low viral load].
Liu PT; Xing H; Liao LJ; Leng XB; Wang J; Kan W; Yan J; Zuo ZB; Ruan YH; Shao YM
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):277-281. PubMed ID: 29973007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
